Quantcast

Latest Corticosteroid Stories

2009-08-26 08:10:32

Mayo Clinic Proceedings published a peer-reviewed comparative effectiveness study performed by HealthCore, Inc. in its August edition. The study demonstrated that asthma patients in general had better clinical outcomes with oral controllers than inhaled corticosteroids.

2009-04-17 12:51:11

One lab’s groundbreaking approach to tailoring drugs that meet only a specific target within the body has focused on anti-inflammatory, anti-AIDS and anti-cancer drugs since 1982.

2009-02-18 10:48:19

Children whose asthma improved while taking steroid drugs for several years did not see those improvements continue after stopping the drugs, new results from a comprehensive childhood asthma study show.

2008-12-11 18:53:00

LONDON, Dec. 11 /PRNewswire-FirstCall/ -- On December 11, 2008, the Joint Advisory Committees of the U.S.

2008-11-24 09:11:26

New research reveals an herb commonly used as a sleep aid could save your sight.

2008-10-27 15:00:27

Results to be presented today at the 2008 American College of Rheumatology Annual Scientific Meeting in San Francisco, USA Galapagos NV (Euronext: GLPG) announces that Nanocort has demonstrated safety as well as a faster and more pronounced decrease in rheumatoid arthritis disease symptoms compared to reference medication.

2008-10-06 21:00:11

Thai researchers suggest patients on allergy medicine are better served when they adjust their dose to symptoms.

2008-10-02 15:01:05

OPKO Health, Inc. (AMEX:OPK) today announced that it has acquired exclusive worldwide rights from Teva Pharmaceuticals Industries Ltd. (TEVA) to Teva's proprietary formulation of budesonide for the treatment of various inflammatory and allergic conditions of the eye.

2008-09-11 15:00:09

German scientists say they have determined what conditions cause the body to deposit fat in the liver, possible leading to a fatty liver condition. Scientists have known the body's own glucocorticoid hormones, such as cortisol, promote the development of fatty liver.

2008-07-09 09:00:12

SOUTH SAN FRANCISCO, July 9 /PRNewswire/ -- Cerimon Pharmaceuticals, Inc., announced today it has initiated a Phase II proof-of-concept study of Simulect(R) (basiliximab) for the treatment of noninfectious uveitis, a chronic and potentially sight-threatening inflammation of the eye.


Word of the Day
metagrabolized
  • totally perplexed and mixed up.
The word 'metagrabolized' is also spelled 'metagrobolized'.
Related